Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously

MSoledad Noya; Marcio Andrade‐Campos; Pilar Irun; Laura López de Frutos; MFernanda López‐Fernandez; Pilar Giraldo

Journal ArticleOPEN ACCESS

Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously

Noya M
Andrade‐Campos M
Irun P
et al.

Clinical Case Reports (2018) 6(5) 887-892

DOI: 10.1002/ccr3.1460

N/ACitations

12Readers

Abstract

Report a female diagnosed as type 1 Gaucher disease after a femoral pathologic fracture when she was 55 years old. Enzyme replacement therapy was started, and she achieved therapeutic goals. In 2015, a Ph’ CML with numerous pseudo‐Gaucher cells in bone marrow appears. BCR/ABL was not present at GD diagnosis.

Cite

CITATION STYLE

APA

Noya, Ms., Andrade‐Campos, M., Irun, P., López de Frutos, L., López‐Fernandez, Mf., & Giraldo, P. (2018). Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously. Clinical Case Reports, 6(5), 887–892. https://doi.org/10.1002/ccr3.1460

Gaucher disease and chronic myeloid leukemia: first reported patient receiving enzyme replacement and tyrosine kinase inhibitor therapies simultaneously

Abstract

Cite

Register to see more suggestions